Susan L. Davis Pharm.D.

Susan L. Davis Pharm.D.

Title

Professor (Clinical)

Department

Pharmacy Practice

Office Location

EACPHS, Room 4136

Phone

313-916-8724

Email

sldavis@wayne.edu

Susan L. Davis Pharm.D.

Degrees and Certifications

  • 2005 - Fellowship in Infectious Diseases Outcomes Research, Wayne State University
  • 2003 - Pharmacy Practice Residency, Detroit Receiving Hospital
  • 2002 - Doctor of Pharmacy, University of Michigan

Positions and Employment

  • 2018-Present - Clinical Professor, Wayne State University
  • 2005-Present - Infectious Diseases Pharmacy Specialist, Henry Ford Hospital
  • 2011-2018 - Clinical Associate Professor, Wayne State University
  • 2005-2011 - Clinical Assistant Professor, Wayne State University

Awards and Honors

  • 2015 - WSY EACHPHS Research Excellence Award
  • 2012 - Society of Infectious Diseases Pharmacists, Outstanding Clinical Practice Award
  • 2012 - Wayne State University Doctor of Pharmacy Program, Preceptor of the Year
  • 2008 - ASHP Foundation, Pharmacy Residency Excellent Awards - New Preceptor of the Year, 2008
  • 2007 - SMSHP Committee Service Award
  • 2006 - Roche Preceptor of the Year (selected by graduating PharmD class)
  • 2006 - Henry Ford Hospital LAPP Preceptor of the Year

Professional Memberships

  • 2012-Present - Making a Difference In Infectious Diseases Pharmacotherapy
  • 2003-Present - Society of Infectious Diseases Pharmacists
  • 2003-Present - American Society for Microbiology
  • 2001-Present - American College of Clinical Pharmacy
  • 1998-Present - American Society of Health-Systems Pharmacists
  • 2003-2014 - Infectious Diseases Society of America
  • 2002-2011 - Southeast Michigan Society of Health-System Pharmacists
  • 2002-2010 - Michigan Pharmacist’s Association

Areas of Expertise

  • Antimicrobial stewardship practice, education and research
  • Epidemiology of healthcare associated infections
  • Clinical and economic consequences of antimicrobial resistance

Primary Research Interest

  • Epidemiology of bacterial infections
  • Clinical and economic implications of antimicrobial resistance
  • Optimizing patient outcomes and antimicrobial exposure

Recent Publications

 • Bianchini M, Mercuro NJ, Kenney RM, Peters M, Samuel LP, Swiderek J, Davis SL. Pharmacists improve care of critically-ill patients with community-acquired pneumonia. Am J Health-System Pharm 2019; in press.
Role: I was the senior investigator for this study. The first author was my PGY1 resident, and I supervised all study activities.

• Liu J., Kaye K.S., Mercuro N.J., Davis S.L., Patel T.S., Petty L.A., Pais G.M., Scheetz M.H It is time to define antimicrobial never events. Infect Control Hosp Epidemiol 2019; 40(2): 206
o I am a co-author for this commentary with a multi-disciplinary group from Wayne State, University of Michigan and Northwestern University.

• Claeys KC, Zasowski E.J., Lagnf A.M., Sabagha N., Levine D.P., Davis S.L., Rybak M.J. Development of a Risk-Scoring Tool to Determine Appropriate Level of Care in Acute Bacterial Skin and Skin Structure Infections in an Acute Healthcare Setting. Infectious Diseases and Therapy 2019; 7(4); 495

• Musgrove M.A., Kenney R.M., Kendall R.E., Peters M., Tibbetts R., Samuel L., Davis S.L. Microbiology comment nudge improves pneumonia prescribing. Open Forum Infectious Diseases 5(7): ofy162
I was the primary investigator for this study.

• Rybak MJ, Zasowski EJ, Jorgensen SJ, Lagnf AM, Davis SL, Mendelsohn AB, Margaritis V. Risk Factors for Bloodstream Infections Among an Urban Population with Skin and Soft Tissue Infections: A Retrospective Unmatched Case-Control Study. Infectious Diseases and Therapy 2019; 8(1): 75-85
o Role: I was a co-investigator for this study.

• Ashley ED, Davis SL, Heil EL, Laplante KL, Chahine EB, Bosso JA. Best care for patients is achieved through multidisciplinary stewardship. Clin Infect Dis 2018; 67(10): 1637
o Role: This paper is response of the leadership of three pharmacy organizations following a commentary that stated only physicians were suitable to lead antimicrobial stewardship programs. As a board member of the Society of Infectious Diseases Pharmacists I was one of two members responsible for drafting and editing the letter.

• Mercuro NJ, Kenney RM, Abreu-Lanfranco, O, Davis SL. Ambulatory Quinolone Prescribing: Moving from Opportunity to Implementation. Clin Infect Dis, April 2018, doi.org/10.1093/cid/ciy315
Role: I was the senior investigator for this study. The first author was my fellow, and I supervised all study activities..

• Mercuro NJ, Kenney RM, Samuel L, Tibbetts RJ, Alangaden GJ, Davis SL. Stewardship opportunities in viral pneumonia: why not the immunocompromised? Transplant Infect Dis. 2018:e12854. doi.org/10.1111/tid.12854
Role: I was the senior investigator for this study. The first author was my PGY1 resident/fellow, and I supervised all study activities.

• Jorgensen SCJ, Mercuro NJ, Davis SL, Rybak MJ. Delafloxacin: place in therapy and review of microbiologic, clinical and pharmacologic properties. Infect Dis Ther 2018 Mar 31. doi: 10.1007/s40121-018-0198-x.
Role: : This review article was written by M. Rybak’s fellow (Jorgensen) and my fellow (Mercuro) as a collaborative effort.

• Veve MP, Greene JB, Williams AM, Davis SL, Lu N, Shnayder Y, Li DX, Noureldine SI, Richmon JD, Lin LO, Hanasono MM, Pipkorn P, Jackson RS, Hornig JD, Light T, Wax MK, Yiu Y, Bekeny J, Old M, Hernandez D, Patel UA, Ghanem TA. Multicenter Assessment of Antibiotic Prophylaxis Spectrum on Surgical Infections in Head and Neck Cancer Microvascular Reconstruction. Otolaryngol Head Neck Surg. 2018 Mar 1:194599818756299. doi: 10.1177/0194599818756299.
Role: The first author of this paper was my fellow, under my supervision for study conception, design, analysis and manuscript preparation. I ceded a more prominent authorship position for myself in return for his deserved position as first author. The last author is a surgeon I collaborate with who invited the multicenter co-investigators included among the other authors..

• Athans V, Veve MP, Davis SL. Trowels and Tribulations: Review of Antimicrobial-Impregnated Bone Cements in Prosthetic Joint Surgery. Pharmacotherapy. 2017; 37(12):1565-1577.
Role: I was the senior author on this paper written by my former resident and fellow. It was a strong group effort.

• Claeys KC, Zasowski EJ, Trinh TD, Lagnf AM, Davis SL, Rybak MJ. Antimicrobial stewardship opportunities in critically ill patients with gram negative lower respiratory tract infections: a multicenter cross-sectional analysis. Infect Dis Ther. 2018 Mar;7(1):135-146. doi: 10.1007/s40121-017-0179-5
Role: I was a co-investigator on this study contributing to study design, analysis and manuscript editing.

• Veve MP, Davis SL, Williams AM, McKinnon JE, Ghanem TA. Considerations for antibiotic prophylaxis in head and neck cancer surgery. Oral Oncology. 2017;74:181-187.
Role: This invited review was written by my fellow under my supervision and editing.

• Suleyman, G, Grunwald J, Kenney RM, Davis SL, Zervos MJ, Weinmann A. Impact of antimicrobial stewardship consultation service at an academic institution. Infect Dis Clin Pract. 2017;25(5);268-71.
Role: This study was the work of a physician assistant (J Grunwald) under my and R Kenney’s mentorship.

• Wilson NM, Kenney RM, Alangaden G, Tibbetts RJ, Samuel LP, Davis SL. T2 Magnetic Resonance Assay Improves Timely Management of Candidemia. Journal of Antimicrobial Stewardship (JAMS) 2017; 1(1): 12-18.
Role: I was the senior investigator for this study. The first author was my PGY2 resident, and I supervised all study activities.

• Trinh TD, Zasowski EJ, Claeys KC, Lagnf AM, Kidambi S, Davis SL, Rybak MJ. Multidrug-resistant Pseudomonas aeruginosa lower respiratory tract infections in the intensive care unit: Prevalence and risk factors. Diagn Microbiol Infect Dis 2017;89(1):61-66.
Role: : I was a co-investigator on this study contributing to study design, analysis and manuscript editing.

• Claeys KC, Zasowski EJ, Lagnf AM, Levine DP, Davis SL, Rybak MJ. Novel Application of Published Risk Factors for Methicillin-Resistant S. aureus in Acute Bacterial Skin and Skin Structure Infections. Int J Antimicrob Agents. 2017 doi: 10.1016/j.ijantimicag.2017.05.015
Role: : I was a co-investigator on this study contributing to study design, analysis and manuscript editing..

• Flynt LK, Kenney RM, Zervos MJ, Davis SL. The Safety and Economic Impact of Cefazolin versus Nafcillin for the Treatment of Methicillin- Susceptible Staphylococcus aureus Bloodstream Infections. Infect Dis Ther; 2017. Jun;6(2):225-23
Role: I was the senior investigator for this study. The first author was my PGY1 resident, and I supervised all study activities.

• Starosta K, Davis SL, Kenney RM, Peters M, To L, Kalus JS. Creating objective and measurable PGY1 residency graduation requirements. Am J Health-Syst Pharm. 2017; 74 (6) 389-396
Role: This paper is a collaboration between the residency/fellowship program directors at my practice site and describes a systematic approach to assessment of pharmacy resident progress. 

• Carreno JJ, Kenney RM, Divine G, Vazquez JA, Davis SL. Randomized controlled trial of a strategy to prevent nephrotoxoxicity in patients receiving vancomycin (STOP-NT). Ann Pharmacother. 2017; 51(3):185-193
Role: I was the senior investigator for this study. The first author was my fellow, and I supervised all study activities.

• Zasowski EJ, Trinh TD, Claeys KC, Casapao AM, Sabagha N, Lagnf AM, Klinker KP, Davis SL, Rybak MJ. Multicenter Observational Study of Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections. Antimicrob Agents Chemother. 2017 Jan 24;61(2). pii: e02015-16. doi: 10.1128/AAC.02015-16.
Role: I was a co-investigator on this study contributing to study design, analysis and manuscript editing. Two of the authors are fellows who I co-mentored.

• Claeys KC, Zasowski EJ, Casapao AM, Lagnf AM, Nagel JL, Nguyen CT, Hallesy JA, Compton MT, Kaye KS, Levine DP, Davis SL, Rybak MJ. Daptomycin Improves Outcomes in a Propensity Matched Analysis of Early Daptomycin versus Vancomycin for Methicillin-Resistant S. aureus Bloodstream Infection. Antimicrob Agents Chemother. 2016 Sep 23;60(10):5841-8
Role: I was a co-investigator on this study contributing to study design, analysis and manuscript editing. Two of the authors are fellows who I co-mentored.

• Cook A, Martin C, Rowe AS, Davis SL, Paloucek F. Problems with the current approach to residency research. AJHP 2016; 73(23):1918-20.
Role: I was a co-author on this paper with colleagues from several colleges of pharmacy in the region describing a critical review and recommendations for improving structure and productivity of research requirements for pharmacy residents. Each author was responsible for writing the content for one section and for editing the completed manuscript.

• Athans V, Kenney RM, Wong J, Davis SL. Outpatient use of ceftaroline fosamil versus vancomycin for osteoarticular infection: a matched cohort study. Journal of Antimicrobial Chemotherapy. 2016; 71(12):3568-3574.
Role: I was the senior investigator for this study. The first author was my PGY1 resident, and I supervised all study activities.

• Wagner JL, Kenney RM, Vazquez JA, Ghanem TA, Davis SL. Surgical prophylaxis with gram-negative activity for reduction of surgical site infections after microvascular reconstruction for head and neck cancer. Head and Neck. 2016;38(10):1449-1454.
Role: I was the senior investigator for this study. The first author was my fellow, and I supervised all study activities.

• Rhodes NJ, Wagner JL, Gilbert E, Crew PE, Davis SL, Scheetz MH. Days of therapy and antimicrobial days: similarities and differences between consumption metrics. Infect Control Hosp Epidemiol. 2016;37:971-973
Role: I was a co-investigator on this study contributing to study conception, analysis and manuscript editing. One of the authors was my fellow.

• Veve MP, Wagner JL, Kenney RM, Grunwald JL, Davis SL. Comparison of fosfomycin to ertapenem for outpatient or step-down therapy of extended-spectrum beta-lactamase urinary tract infections. Int J Antimicrob Agents 2016; 48(1):56-60
Role: I was the senior investigator for this study. The first author was my PGY1 resident, and I supervised all study activities.

• Kenney RM, Cole KA, Perry MB, Dumkow LE, Samuel LP, Zervos MJ, Davis SL. Reply to: Urinary Tract Infections: Resistance is futile. Antimicrob Agents Chemother 2016 60(4):2598
Role: This was a reply to a comment following-up on paper #14. As the senior author I lead the concept and writing of this letter.

• Zasowski EJ, Claeys KC, Lagnf AM, Davis SL, Rybak MJ. Time is of the essence: the impact of delayed antibiotic therapy on patient outcomes in hospital-onset enterococcal bloodstream infections. Clin Infect Dis 2016;62(10):1242-50.
Role: I was a co-investigator on this study contributing to study design, analysis and manuscript editing. Two of the authors are fellows who I co-mentored.

• Claeys KC, Lagnf AM, Hallesy JA, Compton MT, Gravelin AL, Davis SL, Rybak MJ. Pneumonia caused by methicillin-resistant Staphylococcus aureus: does vancomycin heteroresistance matter? Antimicrob Agents Chemother 2016; 60(3):1708-16
Role: I was a co-investigator on this study contributing to study design, analysis and manuscript editing. One of the authors is a fellow who I co-mentored.

• Cole KA, Kenney RM, Perri MB, Dumkow LE, Samuel LP, Zervos MJ, Davis SL. Outcomes of Aminopenicillin Therapy for Vancomycin-Resistant Enterococcal Urinary Tract Infections. Antimicrobial Agents and Chemotherapy. 2015 Dec;59(12):7362-6.
Role: I was the senior investigator for this study. Two of the authors were my PGY2 residents, and I supervised all study activities.

• Athans V, Santarossa M, Kenney RM, Davis SL. Systematic approach to antimicrobial restriction. Am J Health Syst Pharm. 2015 Aug 1;72(15):1264-5.
Role: This brief report describes the evidence-based evaluation process I developed for assessment of antimicrobial use criteria at my practice site. Two of the authors were my PGY2 resident and student, and I supervised all manuscript preparation.

• Carreno JJ, Kenney RM, Bloome M, McDonnell J, Rodriguez J, Weinmann A, Kilgore PE, Davis SL. Evaluation of pharmacy generalists performing antimicrobial stewardship services. Am J Health Syst Pharm. 2015 Aug 1;72(15):1298-303.
Role: I was the senior investigator for this study. The first author was my fellow, and I supervised all study activities.

• Claeys KC, Lagnf AM, Patel TB, Jacob MG, Davis SL, Rybak MJ. Acute Bacterial Skin and Skin Structure Infections Treated with Intravenous Antibiotics in the Emergency Department or Observational Unit: Experience at the Detroit Medical Center. Infect Dis Ther. 2015 Jun;4(2):173-86.
Role: I was a co-investigator on this study contributing to study design, analysis and manuscript editing. One of the authors is a fellow who I co-mentored.

• Wagner JL, Kenney RM, Tibbetts RJ, Davis SL. Secular trends associated with Enterobacteriaceae with a Cefepime-susceptible-dose-dependent MIC. Antimicrob Agents Chemother; 2015:59(3):1822-3
Role: I was the senior investigator for this study. The first author was my fellow, and I supervised all study activities.

• Casapao AM, Lodise TP, Davis SL, Claeys KC, Kullar R, Levine DP, Rybak MJ. The Association between the Vancomycin Day 1 Exposure Profile and Outcomes Among Patients with Methicillin-Resistant Staphylococcus aureus Infective Endocarditis. Antimicrob Agents Chemother. 2015 Mar 9.
Role: I was a co-investigator on this study contributing to study design, analysis and manuscript editing. Two of the authors are fellows who I co-mentored.

• Claeys KC, Smith JR, Mynatt RP, Avery L, Schroff A, Yamamura D, Davis SL, Rybak MJ. Impact of the Combination Daptomycin and Trimethoprim-Sulfamethoxazole on Clinical Outcomes in Methicillin-Resistant S. aureus Infections. Antimicrob Agents Chemother. 2015 Jan 20.
Role: I was a co-investigator on this study contributing to study design, analysis and manuscript editing. Two of the authors are fellows who I co-mentored.

• Dumkow LE, Kenney RM, MacDonald NC, Carreno JJ, Malhotra MK, Davis SL. Impact of a multidisciplinary culture follow-up program in the emergency department. Infect Dis Ther. Infect Dis Ther. 2014;3(1):45-53.
Role: I was the senior investigator for this study. The first author was my PGY1 resident, another author was my fellow, and I supervised all study activities. This study received an Pharmacy Research Excellence Award from the American Society of Health-System Pharmacy Foundation

• Casapao AM, Davis SL, McRoberts JP, Lagnf AM, Patel S, Kullar R, Levine DP, Rybak MJ. Evaluation of Vancomycin Population Analysis Profile Susceptibility as a Predictor of Patient Outcomes with Methicillin-Resistant Staphylococcus aureus Infective Endocarditis. Antimicrob Agents Chemother. 2014;58(8):4636-41.
Role: I was a co-investigator on this study contributing to study design, analysis and manuscript editing. One of the authors is a fellow who I co-mentored.

• Casapao AM, Davis SL, Barr VO, Klinker KP, Goff DA, Barber KE, Kaye KS, Mynatt RP, Molloy LM, Pogue JM, Rybak MJ. A large retrospective evaluation of the effectiveness and safety of ceftaroline fosamil therapy. Antimicrob Agents Chemother. 2014 May;58(5):2541-6.
Role: I was a co-investigator on this study contributing to study design, analysis and manuscript editing. One of the authors is a fellow who I co-mentored.